LMNL实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Sep 2023 @ 03:59):

Stats
今日成交量	5 055.00
平均成交量	23 725.00
市值	27.62M
EPS	$0 ( 2024-03-13 )
下一个收益日期	( $0 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.245
ATR14	$0.0410 (0.48%)

音量相关性

長: 0.13 (neutral)

短: -0.52 (weak negative)

Signal:(77.099) Neutral

Liminal BioSciences Inc 相关性

10 最正相关
BCLI	0.848
GOODM	0.836
AEYE	0.833
BUFF	0.831
ACHV	0.828
RDWR	0.824
TBLD	0.819
CMPR	0.819
BOSC	0.815
TAYD	0.814

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Liminal BioSciences Inc 相关性 - 货币/商品

0.83
( strong )

0.70
( moderate )

-0.70
( moderate negative )

0.51
( weak )

-0.34
( neutral )

Liminal BioSciences Inc 财务报表

Annual	2022
营收:	$401 000
毛利润:	$401 000 (100.00 %)
EPS:	$-9.32

FY	2022
营收:	$401 000
毛利润:	$401 000 (100.00 %)
EPS:	$-9.32

FY	2021
营收:	$643 000
毛利润:	$0.00 (0.00 %)
EPS:	$0.430

FY	2020
营收:	$3.32M
毛利润:	$1.28M (38.71 %)
EPS:	$-4.83

Financial Reports:

No articles found.

Liminal BioSciences Inc

Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the treatment of idiopathic pulmonary, liver, cardiac, or skin fibrosis with fezagepras or related derivatives and respiratory diseases. It is also developing antagonist candidate programs, including G-protein coupled receptor 84 and Oxo-eicosanoid receptor 1, which are in preclinical stage. The company was formerly known as Prometic Life Sciences Inc. and changed its name to Liminal BioSciences Inc. in October 2019. Liminal BioSciences Inc. was incorporated in 1994 and is headquartered in Laval, Canada.

实时更新： Liminal BioSciences Inc [LMNL]

Upcoming Earnings Alert